Phosphodiesterase Type 5 Inhibitors for the Treatment of Male Lower Urinary Tract Symptoms

Both lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) and erectile dysfunction have a very high prevalence among aging men, and there is some clinical evidence that they may share a common pathophysiology. Consequently, several preliminary studies of phosphodiesterase type 5 in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kaplan, Steven A, Gonzalez, Ricardo R
Formato: Artigo
Idioma:Inglês
Publicado: MedReviews, LLC 2007
Assuntos:
Treatment Update
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1892621/
https://ncbi.nlm.nih.gov/pubmed/17592540
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares